WallStSmart

The Ensign Group Inc (ENSG)vsFresenius Medical Care Corporation (FMS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Fresenius Medical Care Corporation generates 267% more annual revenue ($19.36B vs $5.27B). ENSG leads profitability with a 6.9% profit margin vs 4.9%. FMS appears more attractively valued with a PEG of 0.79. ENSG earns a higher WallStSmart Score of 63/100 (C+).

ENSG

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 6.0Value: 4.7Quality: 6.5
Piotroski: 4/9Altman Z: 2.15

FMS

Buy

50

out of 100

Grade: C-

Growth: 2.7Profit: 5.0Value: 9.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ENSGSignificantly Overvalued (-45.7%)

Margin of Safety

-45.7%

Fair Value

$145.42

Current Price

$170.30

$24.88 premium

UndervaluedFair: $145.42Overvalued
FMSUndervalued (+69.0%)

Margin of Safety

+69.0%

Fair Value

$77.65

Current Price

$22.03

$55.62 discount

UndervaluedFair: $77.65Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ENSG2 strengths · Avg: 8.0/10
Revenue GrowthGrowth
18.4%8/10

18.4% revenue growth

EPS GrowthGrowth
21.9%8/10

Earnings expanding 21.9% YoY

FMS3 strengths · Avg: 9.3/10
P/E RatioValuation
11.9x10/10

Attractively priced relative to earnings

Price/BookValuation
0.8x10/10

Reasonable price relative to book value

PEG RatioValuation
0.798/10

Growing faster than its price suggests

Areas to Watch

ENSG1 concerns · Avg: 3.0/10
Profit MarginProfitability
6.9%3/10

6.9% margin — thin

FMS4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Return on EquityProfitability
7.1%3/10

ROE of 7.1% — below average capital efficiency

Profit MarginProfitability
4.9%3/10

4.9% margin — thin

Revenue GrowthGrowth
-5.5%2/10

Revenue declined 5.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth, EPS Growth. Revenue growth of 18.4% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bull Case : FMS

The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.79 suggests the stock is reasonably priced for its growth.

Bear Case : ENSG

The primary concerns for ENSG are Profit Margin.

Bear Case : FMS

The primary concerns for FMS are Altman Z-Score, Return on Equity, Profit Margin. Thin 4.9% margins leave little buffer for downturns.

Key Dynamics to Monitor

ENSG profiles as a growth stock while FMS is a value play — different risk/reward profiles.

FMS carries more volatility with a beta of 0.81 — expect wider price swings.

ENSG is growing revenue faster at 18.4% — sustainability is the question.

ENSG generates stronger free cash flow (65M), providing more financial flexibility.

Bottom Line

ENSG scores higher overall (63/100 vs 50/100) and 18.4% revenue growth. FMS offers better value entry with a 69.0% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Fresenius Medical Care Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Visit Website →

Want to dig deeper into these stocks?